Ignite Creation Date:
2024-05-05 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 9:54 AM
Study NCT ID:
NCT00742339
Status:
TERMINATED
Last Update Posted:
2014-10-15
First Post:
2008-08-26
Brief Title:
Terlipressin Albumin Versus Midodrine Octreotide in the Treatment of Hepatorenal Syndrome
Sponsor:
University of Padova
Organization:
University of Padova
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hepatorenal Syndrome |
| Cirrhosis |
Keywords:
| Name | View |
|---|---|
| All patients with cirrhosis and type 1 HRS | View |
| cirrhosis | View |
| hepatorenal syndrome | View |
| terlipressin | View |
| midodrine | View |
| octreotide | View |
| human albumin | View |
| effective circulating volume | View |
| The criteria which will be used for the diagnosis of HRS will be the criteria which were recently published by the International Ascites Club | View |
| Patients with cirrhosis and type 2 HRS only with serum creatinine value 25 mgdl | View |